Unfortunately for its shareholders, the Dorsavi Ltd (ASX: DVL) share price has continued its disappointing run.
During trade today the motion analysis technology company's shares fell as much as 16% to a 52-week low of 26 cents.
Its shares have since rebounded, but are still down over 46% since the turn of the year. Not even a new contract win has been enough to shift sentiment.
Last week the company announced a three-year deal with Kieser Australia worth approximately $150,000.
The deal will see the recently launched ViMove 2 rolled out across Kieser's network of nine centres in Melbourne and Sydney.
ViMove is dorsaVi's wearable sensor technology used by medical and physiotherapy practices to assess and monitor movement.
The company also provides similar technology to the elite sports market and to the OHS market.